跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Brd4
首页
药物
Brd4
Brd4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SULFONAMIDE OR SULFINAMIDE COMPOUND HAVING EFFECT OF INDUCING BRD4 PROTEIN DEGRADATION AND PHARMACEUTICAL USE THEREOF
EP 4105220 A4
申请人: MITSUBISHI TANABE PHARMA CORP
优先权: 2020
CN
EP
US
WO
8 件公开
TERT-BUTYL 2-(4-PHENYL-6H-THIENO[3,2-F][1,2,4]TRIAZOLO[4,3-A] [1,4]DIAZEPIN-6-YL) ACETATE DERIVATIVES AS BROMODOMAIN BRD4 INHIBITORS FOR TREATING CANCER
EP 4342543 C0
申请人: HOFFMANN LA ROCHE
优先权: 2018
CN
EP
US
WO
7 件公开
COMPOUND HAVING BRD4 INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF
EP 4043462 B1
申请人: HAIHE BIOPHARMA CO LTD
优先权: 2019
CN
EP
US
WO
6 件公开
CHEMICALLY MODIFIED OLIGONUCLEOTIDES TARGETING BROMODOMAIN CONTAINING PROTEIN 4 (BRD4) FOR IMMUNOTHERAPY
EP 4055167 A2
申请人: PHIO PHARM CORP
优先权: 2019
CN
EP
US
WO
4 件公开
THE CDK9 AND BRD4 INHIBITORS FLAVOPIRIDOL AND JQ1 TO INHIBIT CARTILAGE INFLAMMATION
EP 3206749 B1
申请人: UNIV CALIFORNIA
优先权: 2014
EP
US
WO
4 件公开
BRD4 PROTEIN DEGRADATION AGENT COMPOUND, AND PREPARATION METHOD AND USE THEREFOR
EP 4786472 A1
申请人: MIRACURE BIOTECHNOLOGY LTD
优先权: 2023
CN
EP
WO
3 件公开
Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors
US 10689395 B2
申请人: JUBILANT BIOSYS LTD
优先权: 2015
CN
US
3 件公开
Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof
US 11279703 B2
申请人: APTOSE BIOSCIENCES INC
优先权: 2016
CN
US
2 件公开
Inhibitors of bromodomain-containing protein 4 (BRD4)
US 11117865 B2
申请人: ZHOU JIA
优先权: 2016
CN
US
2 件公开
BRD4 inhibitor
US 11572371 B2
申请人: HINOVA PHARMACEUTICALS INC
优先权: 2017
CN
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈